By Product Type
By Research Area
What matters to Proteintech is the success of its antibodies in the hands of scientists. Here’s just a small selection of recent high impact publications featuring Proteintech antibodies.
Genome-embedded ribonucleotides are known as most abundant aberrant nucleotides in the genome of cycling cells. Zimmermann and colleagues suggest that manipulation of genomic ribonucleotide processing could be harnessed for therapeutic purposes and this strategy may expand the use of PARP inhibitors to some tumors that are proficient in homologous recombination.
Michal Zimmermann et al.
Investigation into cell fate conversion using single-cell RNA sequencing and mouse genetics of venous to arterial cells.
Tianying Su et al.
Pubmed ID: 29973725